Muhiddin K A, Johnston A, Turner P
Br J Clin Pharmacol. 1984 Apr;17(4):447-51. doi: 10.1111/j.1365-2125.1984.tb02370.x.
The effect of urinary pH on flecainide excretion has been evaluated in six healthy subjects after a single oral dose of 300 mg flecainide administered as the acetate salt. The cumulative urinary excretion of unchanged flecainide under acidic conditions (134.0 +/- 16.1 mg; mean +/- s.e. mean) was significantly higher than under alkaline conditions (22.3 +/- 7.6 mg; mean +/- s.e. mean) (P less than 0.01). Under alkaline conditions, tmax (time to reach peak concentration) was reduced (P less than 0.01), while elimination half-life, AUC(0-32) and AUC(0-infinity) were increased (P less than 0.01).
在六名健康受试者单次口服300毫克醋酸盐形式的氟卡尼后,评估了尿液pH值对氟卡尼排泄的影响。在酸性条件下,未改变的氟卡尼累积尿排泄量(134.0±16.1毫克;平均值±标准误)显著高于碱性条件下(22.3±7.6毫克;平均值±标准误)(P<0.01)。在碱性条件下,达峰时间(tmax)缩短(P<0.01),而消除半衰期、AUC(0 - 32)和AUC(0 - ∞)增加(P<0.01)。